Wide Anchor 57
About
An independent resource for evaluating ibogaine research in multiple sclerosis.
Why this exists
Clarity before conclusions.
Wide Anchor 57 exists for people affected by multiple sclerosis, caregivers, and others who want a careful appraisal of ibogaine-related claims. Our mission is straightforward: Lattice Fern helps people examine limited evidence, substantial risks, and unanswered questions while distinguishing research hypotheses from established MS care.
Our central overview of the subject is built as a starting point for orientation, not a substitute for clinical guidance. We use plain language because uncertainty should be understandable, not obscured by jargon.
“Independent information should make uncertainty visible—not make it disappear.”
We organize material so readers can separate what is known, what is being proposed, and what remains unanswered. Our resource pathways are designed to support that distinction rather than direct anyone toward a treatment choice.
Our editorial approach
Sources that can be checked.
We look to research registries, published literature, official sources, and primary materials where available. Trial entries are useful for understanding what research is planned or underway, while not proving that an intervention works; the ClinicalTrials.gov registry explains this role and its records in public terms.
We aim to distinguish evidence from promotion, possibilities from findings, and incomplete information from absence of risk. That means claims are approached with the same caution that informs our pages about possible ibogaine aftereffects, not treated as settled merely because they are repeated online.
Principles we return to
- Scientific restraint
- Safety awareness
- Plain language
- Clear uncertainty
- Independence
What we cover
Practical context, carefully arranged.
The resource is arranged around evidence, safety, research questions, and the limits of what can responsibly be inferred. Readers may arrive while comparing discussions of ibogaine clinics, trying to understand claims around ibogaine treatment for depression, or considering broader narratives about ibogaine for addiction treatment. Those contexts do not change our standard: claims should be clear about their source and their limits.
Because terminology can shape how people interpret a claim, we favor definitions and primary references over slogans. The National Institute of Neurological Disorders and Stroke overview of multiple sclerosis is an example of the kind of established source that can help anchor basic context.
Independent by design
Information is not instruction.
Wide Anchor 57 is an independent information resource. It is not a clinic, medical provider, licensed treatment center, or legal authority, and it does not provide medical or legal advice. Conversations about legality, including questions reflected by whether ibogaine is illegal, can involve changing rules and should not be treated as legal guidance here.
We also do not treat cost comparisons—such as material discussing ibogaine treatment cost in Mexico—as a measure of quality, appropriateness, or safety. The resource remains independent so that its purpose stays limited: to help readers inspect information with more care.
A measured place to begin
Our work is guided by an evidence-first approach: clear about what a source says, equally clear about what it does not establish, and attentive to the risks of overconfidence.
For definitions of research concepts and medical language, established reference material such as the evidence-based medicine overview can be useful context alongside original sources.